BBVA Q1 2026 Earnings EPS Beats Estimates as Net Interest Income Strengthens Stock Edges Lower DLPN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter LITB Q4 2024 Earnings Reports Positive EPS Amid Limited Disclosure SPRU Q1 2026 Earnings EPS Loss of 016 Per Share No Revenue Disclosed SVRA Q1 2026 Earnings Wider Loss Amid Continued Pipeline Development Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending